TY - JOUR T1 - A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope? JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00113-2020 VL - 6 IS - 2 SP - 00113-2020 AU - J. Michael Ramsahai AU - Jodie L. Simpson AU - Liam Heaney AU - Nicola Gallagher AU - Peter A.B. Wark Y1 - 2020/04/01 UR - http://openres.ersjournals.com/content/6/2/00113-2020.abstract N2 - Recently, a survey has been published on the opinions of UK and Europeans specialists regarding the use of biomarkers in asthma [1]. The results highlight that despite the growing body of research, and the wealth of targets in blood, sputum, tissue and breath, there has been little change in the application of biomarkers to clinical practice. While the virtues of precision medicine continue to be extolled, practically there has been little enthusiasm in real-world clinics. To investigate the factors behind this and whether this holds true outside Europe, we have mirrored the approach of Gallagher et al. [1] and conducted a Delphi survey of specialist physicians in Australia to gauge their opinions on the application of biomarkers in severe asthma (Figure 1).Asthma specialists are interested in adopting biomarkers into clinical practice, but more work needs to be done to support resources towards their use and provide clearer direction on this. This concern is not limited to European specialists. https://bit.ly/2WWEQXb ER -